mecamylamine has been researched along with raclopride in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clementi, F; Dallanoce, C; De Amici, M; Fiorentini, C; Fucile, S; Gotti, C; Grazioso, G; Matera, C; Missale, C; Pucci, L; Zoli, M | 1 |
Butcher, LL; Levin, ED; McGurk, SR | 1 |
Greengard, P; Hamada, M; Higashi, H; Nairn, AC; Nishi, A | 1 |
3 other study(ies) available for mecamylamine and raclopride
Article | Year |
---|---|
Bifunctional compounds targeting both D2 and non-α7 nACh receptors: design, synthesis and pharmacological characterization.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Design; HEK293 Cells; Humans; Molecular Structure; Nicotinic Antagonists; Receptors, Dopamine D2; Structure-Activity Relationship; Substrate Specificity | 2015 |
Radial-arm maze performance in rats is impaired by a combination of nicotinic-cholinergic and D2 dopaminergic antagonist drugs.
Topics: Animals; Benzazepines; Dopamine Antagonists; Drug Interactions; Female; Ganglionic Stimulants; Haloperidol; Mecamylamine; Parasympathomimetics; Psychomotor Performance; Raclopride; Rats; Rats, Inbred Strains; Salicylamides; Scopolamine | 1989 |
Differential regulation of dopamine D1 and D2 signaling by nicotine in neostriatal neurons.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Benzazepines; Blotting, Western; Bungarotoxins; Cyclosporine; Dihydro-beta-Erythroidine; Dizocilpine Maleate; Dopamine and cAMP-Regulated Phosphoprotein 32; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; In Vitro Techniques; Male; Mecamylamine; Mice; Mice, Inbred C57BL; Models, Neurological; Neostriatum; Nerve Tissue Proteins; Neurons; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Phosphoproteins; Phosphorylation; Raclopride; Receptors, Dopamine D1; Receptors, Dopamine D2; Tetrodotoxin; Threonine | 2004 |